FMT
APLS

First Mercantile Trust’s Apellis Pharmaceuticals APLS Stock Holding History

First Mercantile Trust’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$65K Sell
1,975
-415
-17% -$23.3K 0.01% 745
2021
Q2 		$151K Sell
2,390
-270
-10% -$13.9K 0.02% 541
2021
Q1 		$114K Sell
2,660
-312
-10% -$14.8K 0.01% 640
2020
Q4 		$170K Sell
2,972
-844
-22% -$35.7K 0.02% 497
2020
Q3 		$137K Buy
3,816
+1
+0% +$30 0.02% 567
2020
Q2 		$125K Buy
+3,815
New +$123K 0.02% 573

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Mercantile Trust's APLS Position: Q3 2021 in Review

First Mercantile Trust reduced its Apellis Pharmaceuticals (APLS) stake by 17% in Q3 2021, selling an estimated $23.3K and leaving 1,975 shares worth $65K. The position accounts for 0.01% of the portfolio, ranked #745.

First Mercantile Trust first reported a position in APLS in Q2 2020 and has held it in 6 quarters since. The position peaked at $170K in Q4 2020. 180 funds tracked by Wall St. Rank hold APLS as of Q3 2021.

  • First Mercantile Trust held 1,975 shares of Apellis Pharmaceuticals worth $65K as of Q3 2021.
  • First Mercantile Trust sold 415 Apellis Pharmaceuticals shares in Q3 2021, an estimated $23.3K.
  • Apellis Pharmaceuticals made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #745 holding.
  • First Mercantile Trust first reported a position in Apellis Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
  • First Mercantile Trust's Apellis Pharmaceuticals position peaked at $170K in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.